THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $624,000 | -3.3% | 30,564 | -29.9% | 0.00% | 0.0% |
| Q3 2020 | $645,000 | -60.4% | 43,608 | -43.8% | 0.00% | -66.7% |
| Q2 2020 | $1,629,000 | -21.2% | 77,585 | -13.2% | 0.00% | -40.0% |
| Q1 2020 | $2,066,000 | +57.5% | 89,416 | +76.4% | 0.01% | +150.0% |
| Q4 2019 | $1,312,000 | -30.3% | 50,692 | -39.0% | 0.00% | -50.0% |
| Q1 2019 | $1,882,000 | -16.1% | 83,039 | -5.2% | 0.00% | -20.0% |
| Q4 2018 | $2,243,000 | +210.2% | 87,633 | +315.0% | 0.01% | +150.0% |
| Q3 2017 | $723,000 | +46.1% | 21,118 | +70.1% | 0.00% | +100.0% |
| Q2 2017 | $495,000 | -12.1% | 12,418 | -18.8% | 0.00% | -50.0% |
| Q1 2017 | $563,000 | -55.6% | 15,298 | -61.5% | 0.00% | -50.0% |
| Q4 2016 | $1,267,000 | – | 39,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |